| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/21/2008 | US20080200420 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
| 08/21/2008 | US20080200407 Suppress the immunoreactivity of a CpG motif and preventing and treating immune-mediated diseases such as arthritis |
| 08/21/2008 | US20080200383 Long-term stability, extended delivery using a suitable reservoir; pumped or metered at a controlled rate; implantable or external pump device, pen style injection device; stable at physiologic temperatures for duration of therapeutic exposure; supply of therapeutically active material for up to 2 years |
| 08/21/2008 | US20080200376 Compositions and Methods For the Treatment Of Obesity and Sexual Dysfunction |
| 08/21/2008 | US20080200371 Thiazole and thiadiazole inhibitors of tyrosine phosphatases |
| 08/21/2008 | US20080200366 Modulating melanocortin receptors |
| 08/21/2008 | US20080199543 Pharmaceutically Active Extracts of Vitex Leucoxylon, a Process of Extracting the Same and a Method of Treating Diabetes and Inflammatory Diseases Therewith |
| 08/21/2008 | US20080199534 Mixture containing metal compound and oxidizable vitamin; stabilization |
| 08/21/2008 | US20080199480 Methods for Identifying Risk of Type II Diabetes and Treatments Thereof |
| 08/21/2008 | US20080199465 Accelerated lymphocyte homing agent such as fingolimod and one or more compounds selected from an antibody to the IL-2 receptor, an immunosuppressive macrocyclic lactone and a soluble human complement inhibitor |
| 08/21/2008 | US20080199435 IL-8 Like Protein |
| 08/21/2008 | US20080199413 Novel Use of Organic Compounds |
| 08/21/2008 | DE102007007751A1 Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel New substituted Arylsulfonylglycine, their preparation and their use as medicaments |
| 08/21/2008 | CA2728541A1 Crystalline forms of thiazolidinedione compound and its manufacturing method |
| 08/21/2008 | CA2678382A1 New substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions |
| 08/21/2008 | CA2678325A1 Use of ranolazine for the treatment of non-coronary microvascular diseases |
| 08/21/2008 | CA2678319A1 Use of ranolazine for the treatment of coronary microvascular diseases |
| 08/21/2008 | CA2677931A1 Use of ranolazine for the treatment of cardiovascular diseases |
| 08/21/2008 | CA2677818A1 The secreted protein ccdc80 regulates adipocyte differentiation |
| 08/21/2008 | CA2677782A1 Anti fgf23 antibody and a pharmaceutical composition comprising the same |
| 08/21/2008 | CA2677747A1 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines |
| 08/21/2008 | CA2677736A1 Fused ring compounds as partial agonists of ppar-gamma |
| 08/21/2008 | CA2677452A1 Compositions for increasing body weight, use and methods |
| 08/21/2008 | CA2676154A1 Pyrazole derivatives as 11-beta-hsd1 inhibitors |
| 08/21/2008 | CA2673534A1 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitors |
| 08/21/2008 | CA2673532A1 New phenyl-(4-phenyl-pyrimidin-2-yl)-amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
| 08/21/2008 | CA2672959A1 New n, n'- 2,4-dianilinopyrimidine derivatives, preparation thereof as drugs, pharmaceutical compositions essentially as ikk inhibitors |
| 08/21/2008 | CA2672955A1 New 2, 4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors |
| 08/20/2008 | EP1958941A1 Oxazolidinones and their use as hypocholesterolemic agents |
| 08/20/2008 | EP1958636A1 Pharmaceutical compositions containing combined antidiabetic substances for use in type 2 diabetes mellitus |
| 08/20/2008 | EP1958503A2 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 08/20/2008 | EP1957484A2 Glucagon receptor antagonists, preparation and therapeutic uses |
| 08/20/2008 | EP1957479A2 1,5-substituted indol-2-yl amide derivatives |
| 08/20/2008 | EP1957452A1 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium |
| 08/20/2008 | EP1957444A2 2,3,4,5-tetrahydroxy-6-sulfooxyhexanoic acid and its metal salts for medical use |
| 08/20/2008 | EP1957068A2 Glucagon receptor antagonists, preparation and therapeutic uses |
| 08/20/2008 | EP1896077A4 Methods and compositions for the prevention and treatement of inflammatory disease |
| 08/20/2008 | EP1778624B1 Tyrosine derivatives as ppar-gamma-modulators |
| 08/20/2008 | EP1685102A4 Melanocortin receptor agonists |
| 08/20/2008 | EP1616873B1 Lipid-regulating agent and use thereof |
| 08/20/2008 | EP1603927B1 Optically detectable (alkylacyl-2-aminodesoxy-glycero)-nitrophenyl-phosphonates |
| 08/20/2008 | EP1556488B1 Hf-chondroosteomodulin, production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 08/20/2008 | EP1509618B1 Autoimmune conditions and nadph oxidase defects |
| 08/20/2008 | EP1509223B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 08/20/2008 | EP1482976B1 A preparation and method for weight reduction |
| 08/20/2008 | EP1482935B1 Thiazole and oxazole derivatives which modulate ppar activity |
| 08/20/2008 | EP1456203B1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 08/20/2008 | EP1451202B1 Aryl fused azapolycyclic compounds |
| 08/20/2008 | EP1446500B1 A method for regulating immune function in primates using the foxp3 protein |
| 08/20/2008 | EP1404653B1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 08/20/2008 | EP1357973B1 Gssp4 polynucleotides and polypeptides and uses thereof |
| 08/20/2008 | EP1318993B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 08/20/2008 | EP1289993B9 Caspase inhibitors and uses thereof |
| 08/20/2008 | EP1249233B1 Npyy5 antagonists |
| 08/20/2008 | EP1240823B1 N-calcium channel knockout animal |
| 08/20/2008 | EP1075493B1 Dna encoding snorf25 receptor |
| 08/20/2008 | EP0883404B1 Combination therapy for osteoporosis |
| 08/20/2008 | CN101248065A Activator of peroxisome proliferator activated receptor delta |
| 08/20/2008 | CN101248063A Prodrugs of pyrazoline compounds, their preparation and use as medicaments |
| 08/20/2008 | CN101248049A 咪唑类lxr调节剂 Imidazole lxr modifier |
| 08/20/2008 | CN101248048A Imidazole based LXR modulators |
| 08/20/2008 | CN101248043A Novel 2-azetidinone derivatives as cholesterol absorption inhibitors useful for the treatment of hyperlipidaemic conditions |
| 08/20/2008 | CN101247797A Inhibitors of anorexic lipid hydrolysis for the treatment of eating disorders |
| 08/20/2008 | CN101245112A Polyoses extracted from pistacia chinensis meal and extracting method thereof |
| 08/20/2008 | CN101244988A Method for extracting paclitaxel extract, extracting and purifying sequoyitol |
| 08/20/2008 | CN101244987A Method for extracting and purifying sequoyitol by using solvent circulation reflux |
| 08/20/2008 | CN101244245A Chinese medicine composition for blood circulation activating and stasis removing |
| 08/20/2008 | CN101244211A Shencao target fat eliminating ointment |
| 08/20/2008 | CN101244210A Shencao target fat eliminating essential oil |
| 08/20/2008 | CN101244205A Vein relaxing antihypelipidemic product based on reestablishment entatic state theory and preparation method |
| 08/20/2008 | CN101244202A Chinese medicine oral administration solid preparations, preparation, quality control method and uses thereof |
| 08/20/2008 | CN101244201A Chinese medicine composition for treating diabetes and method for preparing the same |
| 08/20/2008 | CN101244198A Traditional Chinese medicine for treating diabetes |
| 08/20/2008 | CN101244157A Natural plants extract, preparation method and application thereof |
| 08/20/2008 | CN101244154A Pharmaceutical combination for bearing and rearing better children, preventing birth defect and improving anamnesis |
| 08/20/2008 | CN101244134A New purpose of naodesheng extract for treating diabetes complication |
| 08/20/2008 | CN101244121A Leonurus heterophyllus total alkaloid extract and preparation thereof |
| 08/20/2008 | CN101244120A Method for preparing sianchau particle medicinal granules with multiple health care functions |
| 08/20/2008 | CN101244119A Method for extracting polyoses and active principle from cyclocarya paliurus |
| 08/20/2008 | CN101244118A Method for preparing natural plants extract |
| 08/20/2008 | CN101244112A Application method of blood sugar reduction active component extracted from momordica grosvenori plant strain |
| 08/20/2008 | CN101244106A Yacon antidiabetic extract and preparation method |
| 08/20/2008 | CN101244083A Block shaped instant glue preparation product and preparation method |
| 08/20/2008 | CN101244082A Animal bone calcium and preparation thereof |
| 08/20/2008 | CN101244081A Bone nourishing calcium tablet |
| 08/20/2008 | CN101244080A Pharmaceutical combination for preventing birth defect and improving anamnesis |
| 08/20/2008 | CN101244079A Iron supplement composition, its preparing method and application of the same |
| 08/20/2008 | CN101244062A Sustained release pharmaceutical compositions and methods of treatment using the same |
| 08/20/2008 | CN101244060A Leonurus heterophyllus alkaloid composition and method of preparing the same |
| 08/20/2008 | CN101244057A 3-substituted oxygen group-3',4'-dimethoxy flavonoid compound with blood fat reducing function |
| 08/20/2008 | CN101244052A Oral administration solid preparation containing component for reducing blood fat |
| 08/20/2008 | CN101244042A Folic acid freeze-dried injection and preparation thereof |
| 08/20/2008 | CN101244037A High concentration middle/long fatty milk injection for injection and preparing method thereof |
| 08/20/2008 | CN101243883A Health food with function of reducing blood sugar and its preparation |
| 08/20/2008 | CN101243864A Application of flatstem milkvetch seed as fatigue resistant health food |
| 08/20/2008 | CN101243851A Nourishing kudzu root trunk (kudzu betel nut) formula and preparing process |
| 08/20/2008 | CN100412091C Analogs of parathyroid hormone |
| 08/20/2008 | CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 08/20/2008 | CN100411677C Pharmaceutical composition and its preparing method and usage |
| 08/20/2008 | CN100411653C Chinese medicine composition for treating diabetes mellitus, its preparation and use |